PRMT9 and neoplasm: Notably, Prmt9 levels were more abundant in leukemic cells than other cells; Prmt9 KD decreased tumor cell frequency relative to controls (Fig. 5j and Extended Data Fig. 7f,g) and induced T cell activation (Fig. 5k).